v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Sales Agreement [Member]
Common Stock [Member]
Common Stock [Member]
At The Market Sales Agreement [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
At The Market Sales Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023 $ 82,547   $ 68   $ 321,642   $ (29) $ (239,134)
Beginning Balance (in shares) at Dec. 31, 2023     68,283,699          
Stock-based compensation 1,850       1,850      
Issuance of common stock from exercise of stock options 218       218      
Issuance of common stock from exercise of stock options (in shares)     129,518          
Issuance of common stock, net of commissions and allocated fees, less issuance costs   $ 4,834   $ 2   $ 4,832    
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)       1,474,926        
Issuance of common stock from Employee Stock Purchase Plan 34       34      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     30,675          
Issuance of common stock from pre-funded warrant exercise     $ 3   (3)      
Issuance of common stock from pre-funded warrant exercise (in shares)     2,673,099          
Unrealized losses on available-for-sale marketable securities (55)           (55)  
Net loss (23,254)             (23,254)
Ending Balance at Jun. 30, 2024 66,174   $ 73   328,573   (84) (262,388)
Ending Balance (in shares) at Jun. 30, 2024     72,591,917          
Beginning Balance at Dec. 31, 2023 82,547   $ 68   321,642   (29) (239,134)
Beginning Balance (in shares) at Dec. 31, 2023     68,283,699          
Ending Balance at Dec. 31, 2024 99,644   $ 94   386,534   61 (287,045)
Ending Balance (in shares) at Dec. 31, 2024     93,602,631          
Beginning Balance at Mar. 31, 2024 72,334   $ 69   322,368   (67) (250,036)
Beginning Balance (in shares) at Mar. 31, 2024     68,960,167          
Stock-based compensation 1,127       1,127      
Issuance of common stock from exercise of stock options 214       214      
Issuance of common stock from exercise of stock options (in shares)     126,887          
Issuance of common stock, net of commissions and allocated fees, less issuance costs   $ 4,834   $ 2   $ 4,832    
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)       1,474,926        
Issuance of common stock from Employee Stock Purchase Plan 34       34      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     30,675          
Issuance of common stock from pre-funded warrant exercise     $ 2   (2)      
Issuance of common stock from pre-funded warrant exercise (in shares)     1,999,262          
Unrealized losses on available-for-sale marketable securities (17)           (17)  
Net loss (12,352)             (12,352)
Ending Balance at Jun. 30, 2024 66,174   $ 73   328,573   (84) (262,388)
Ending Balance (in shares) at Jun. 30, 2024     72,591,917          
Beginning Balance at Dec. 31, 2024 99,644   $ 94   386,534   61 (287,045)
Beginning Balance (in shares) at Dec. 31, 2024     93,602,631          
Stock-based compensation 2,592       2,592      
Issuance of common stock from exercise of stock options $ 731       731      
Issuance of common stock from exercise of stock options (in shares) 295,372   295,372          
Issuance of common stock, net of commissions and allocated fees, less issuance costs $ 107,388   $ 20   107,368      
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)     20,010,000          
Issuance of common stock from Employee Stock Purchase Plan 59       59      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     15,898          
Issuance of common stock from warrant exercise 10,757   $ 8   10,749      
Issuance of common stock from warrant exercise (in shares)     7,851,852          
Unrealized losses on available-for-sale marketable securities (37)           (37)  
Net loss (22,641)             (22,641)
Ending Balance at Jun. 30, 2025 198,493   $ 122   508,033   24 (309,686)
Ending Balance (in shares) at Jun. 30, 2025     121,775,753          
Beginning Balance at Mar. 31, 2025 99,457   $ 100   396,669   73 (297,385)
Beginning Balance (in shares) at Mar. 31, 2025     99,892,915          
Stock-based compensation 1,384       1,384      
Issuance of common stock from exercise of stock options 13       13      
Issuance of common stock from exercise of stock options (in shares)     5,088          
Issuance of common stock, net of commissions and allocated fees, less issuance costs 107,393   $ 20   107,373      
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)     20,010,000          
Issuance of common stock from Employee Stock Purchase Plan 59       59      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     15,898          
Issuance of common stock from warrant exercise 2,537   $ 2   2,535      
Issuance of common stock from warrant exercise (in shares)     1,851,852          
Unrealized losses on available-for-sale marketable securities (49)           (49)  
Net loss (12,301)             (12,301)
Ending Balance at Jun. 30, 2025 $ 198,493   $ 122   $ 508,033   $ 24 $ (309,686)
Ending Balance (in shares) at Jun. 30, 2025     121,775,753